3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Conditions
Leukemia, Myeloid, Acute
2
Myelodysplastic Syndromes
1
Leukemia, Promyelocytic, Acute
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
Arsenic Trioxide
4
Tretinoin
2
vadastuximab talirine
1
tamibarotene
1
cyclo-tetrakis(bis(1-phenyl-3-methyl-4-benzoylpyrazolon-5-ato)mu-oxotitanium(IV))
1
Granulocyte Colony-Stimulating Factor
1
Filgrastim
1
Cytarabine
1
Clofarabine
1
AEG 35156
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
INDUSTRY
×
Leukemia, Promyelocytic, Acute
×
tamibarotene
×
Clear all
NCT00520208
2013-02-13
STAR-1
CytRx
Phase 2
Completed
15 enrolled